|
| Scientific Program |
| |
|
| Scientific Program | Search Abstract |
| |
|
|
| Session |
| |
| Anemia, aplastic anemia - PNH |
| Date: |
Saturday, 06 June 2009
|
| Time: | 18:00-19:15 |
| Room: | |
| |
| 18:00-19:15 |
|
GENETIC ANALYSIS OF THE SHELTERIN COMPLEX COMPONENTS (POT1, RAP1, TPP1, TRF1 AND TRF2) IN DYSKERATOSIS CONGENITA
| 0579 |
| Walne, Amanda,
Vulliamy, Tom,
Beswick, Richard,
Kirwan, Michael,
Dokal, Inderjeet
(London, United Kingdom) |
| |
| 18:00-19:15 |
|
IMMUNOSUPPRESSIVE THERAPY WITH RABBIT ANTITHYMOCYTE GLOBULIN (R-ATG) MIGHT BE COMPARABLE TO HORSE ANTILYMPHOCYTE GLOBULIN (H-AG) IN CHILDHOOD SEVERE APLASTIC ANEMIA WITHOUT HLA-IDENTICAL SIBLING DONOR
| 0580 |
| Jeong, Dae-Chul,
Cho, Bin,
Chung, Nack-Gyun,
Jang, Pil-Sang,
Kwon, Young-Joo,
Lee, Dae-Hyeong,
Kim, Sun-Young,
Park, Young-Shil,
Kim, Hack-Ki
(Incheon, South-Korea) |
| |
| 18:00-19:15 |
|
EFFICACY OF THE COMPLEMENT INHIBITOR ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS NEVER TRANSFUSED
| 0581 |
| Risitano, Antonio,
Alfinito, F,
Seneca, E,
Marando, L,
Boschetti, C,
Bonfigli, S,
Fenu, S,
Re, F,
Gosetti, G,
Khursigara, G,
Rother, R,
Zanella, A,
Rotoli, B
(Naples, Italy) |
| |
| 18:00-19:15 |
|
HOME INFUSION OF ECULIZUMAB: A UNIQUE AND INNOVATIVE MODEL OF DRUG DELIVERY TO REDUCE TREATMENT-ASSOCIATED BURDEN AND ENHANCE QUALITY OF LIFE FOR PATIENTS WITH PNH
| 0582 |
| Arnold, Louise,
Stephenson, Jill,
Kelly, Richard Dr,
Buchanan, David,
Hill, Anita Dr,
Stichler, Alex,
Bagabag, Julie,
Jones, Gareth,
Bilbrough, Carol,
Hillmen, Peter Dr
(Leeds, United Kingdom) |
| |
| 18:00-19:15 |
|
USE OF FLAER-BASED ASSAY OF WHITE BLOOD CELLS (MONOCYTES AND GRANULOCYTES) IN THE PRIMARY SCREENING OF PNH CLONES
| 0583 |
| Sutherland, Robert,
Keeney, Michael,
Kuek, Nancy,
Azcona-Olivera, Juan,
Acton, Erica,
Anderson, Tanya,
Barth, David,
Reis, Marciano (P)
(Toronto, Canada) |
| |
| 18:00-19:15 |
|
EFFECT OF ECULIZIMAB THERAPY ON THROMBOCYTOPENIA IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
| 0584 |
| Weitz, Ilene,
Rochanda, Leanne,
Liebman, Howard
(Los Angeles, California, United States of America) |
| |
| 18:00-19:15 |
|
EFFICACY OF THE TERMINAL COMPLEMENT INHIBITOR ECULIZUMAB USED CHRONICALLY IN A PATIENT WITH COLD AGGLUTININ DISEASE (CAD)
| 0585 |
| Röth, Alexander,
Hüttmann, A,
Hock, C,
Rother, R,
Dührsen, U,
Philipp, T
(Essen, Germany) |
| |
| 18:00-19:15 |
|
ANEMIA DURING PEGYLATED INTERFERON-RIBAVIRIN THERAPY RESULTS FROM BOTH INCREASE SUPPRESSION OF ERYTHROID DIFFERENTIATION AND HEMOLYSIS
| 0586 |
| Ronzoni, Luisa,
Aghemo, Alessio,
Rumi, Maria Grazia,
Colancecco, Alessandra,
Monico, Sara,
Grillo, Paolo,
Colombo, Massimo,
Cappellini, Maria Domenica
(Milan, Italy) |
| |
| 18:00-19:15 |
|
MODIFICATION OF THE STANDARD ECULIZUMAB DOSE TO SUCCESSFULLY MANAGE INTRAVASCULAR HAEMOLYSIS BREAKTHROUGH IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA
| 0587 |
| Kelly, Richard,
Arnold, Louise,
Richards, Stephen,
Hill, Anita,
Bijnen, Sandra van,
Muus, Petra,
Dorr, Donna,
Brodsky, Robert,
Beauchamp, Jon,
Khursigara, Gus,
Rother, Russell,
Hillmen, Peter
(Leeds, United Kingdom) |
| |
| 18:00-19:15 |
|
DIAGNOSING IRON DEFICIENCY ANEMIA IN PATIENTS WITH RHEUMATOID ARTHRITIS
| 0588 |
| Dongen-Lases, Edmée van,
Linssen, Anouk,
Vegt, Femmie de,
Riel, Piet van,
Swinkels, Dorine,
Ede, Annelies van
(Nijmegen, Netherlands) |
| |
| 18:00-19:15 |
|
IN VITRO EFFECT OF RIBAVIRIN AND PEGYLATED INTERFERON ON ERYTHROPOIESIS
| 0589 |
| Ronzoni, Luisa,
Colancecco, Alessandra,
Cattaneo, Alessandra,
Aghemo, Alessio,
Rumi, Maria Grazia,
Colombo, Massimo,
Cappellini, Maria Domenica
(Milan, Italy) |
| |
| 18:00-19:15 |
|
ANTI CD 20 (RITUXIMAB) IN PEDIATRIC AUTOIMMUNE HAEMOLYTIC ANAEMIAS. LONG FOLLOW UP IN A SINGLE CENTRE
| 0590 |
| Catala, Albert,
Rives, Susana,
Toll, Teresa,
Camos, Mireia,
Berrueco, Ruben,
Conde, Nuria,
Quintero, Ana,
Estella, Jesus
(Barcelona, Spain) |
| |
| 18:00-19:15 |
|
LONG-TERM OUTCOME OF ACQUIRED APLASTIC ANEMIA: COMPARATION BETWEEN IMMUNOSUPPRESSIVE THERAPY AND BONE MARROW TRANSPLANTATION
| 0591 |
| Tukic, Ljiljana,
Stamatovic, Dragana,
Tarabar, Olivera,
Elez, Marija,
Tatomirovic, Zeljka,
Radic-Tasic, Olga,
Balint, Bela,
Kuljic-Kapulica, Nada
(Belgrade, Serbia) |
| |
| 18:00-19:15 |
|
THALASSEMIA INTERMEDIA: AN EGYPTIAN EXPERIENCE
| 0592 |
| Mokhtar, Galila,
A.G.Tantawy, Azza (P),
A.Abdel Moneim, Amira,
Waheed, Marwa
(Cairo, Egypt) |
| |
| 18:00-19:15 |
|
SUCCESSFUL TREATMENT OF COMPLEMENT MEDIATED REFRACTORY HAEMOLYSIS ASSOCIATED WITH COLD AND WARM AUTOANTIBODIES USING ECULIZUMAB
| 0593 |
| Bommer, Martin,
Höchsmann, Britta,
Flegel, Willy,
Doehner, Hartmut,
Schrezenmeier, Hubert
(Ulm, Germany) |
| |
| 18:00-19:15 |
|
EFFECT OF DIHYDROARTEMISININ (DHA) ON HUMAN ERYTHROID CELL DIFFERENTIATION: IMPLICATIONS FOR MALARIA TREATMENT IN PREGNANCY
| 0594 |
| FINAURINI, SARA,
Ronzoni, Luisa,
Colancecco, Alessandra,
Cappellini, Maria Domenica,
Taramelli, Donatella
(MILAN, Italy) |
| |
| 18:00-19:15 |
|
OSTEOPROTEGERIN AND RECEPTOR ACTIVATOR OF THE NF-?B LIGAND (RANKL) IN EGYPTIAN PATIENTS WITH THALASSEMIA-INDUCED OSTEOPOROSIS
| 0595 |
| Abd El Hamid, Alaa El Din Saad,
Attia, Moustapha,
Saad, Atef,
El Nesr, Magdy,
Saleh, Mai Hassan
(Ismailia, Egypt) |
| |
| 18:00-19:15 |
|
A CHILD WITH DYSKERATOSIS CONGENITA AND RECENTLY DESCRIBED TINF2 MUTATION
| 0596 |
| Sarper, Nazan,
Zengin, Emine
(Kocaeli, Turkey) |
| |
| 18:00-19:15 |
|
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADOLESCENTS AND ADULTS. UNDERESTIMATED PROBLEM?
| 0597 |
| Jedrzejczak, Wieslaw,
Jablonska, Joanna,
Dwilewicz-Trojaczek, Jadwiga,
Ziarkiewicz-Wroblewska, Bogna,
Dzieciatkowski, Tomasz,
Boguradzki, Piotr,
Charlinski, Grzegorz,
Wiater, Elżbieta,
Witkowska, Magdalena,
Waszczuk-Gajda, Anna,
Hensler, Grzegorz,
Tormanowska, Magdalena
(Warsaw, Poland) |
| |
| 18:00-19:15 |
|
TAFI (THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR) AS A MARKER OF HEMOSTATIC ALTERATION IN PATIENTS WITH BETA-THALASSEMIA
| 0598 |
| Matter, Randa,
Mokhtar, Galila (P),
Abdel Aziz, Manal,
Mortagi, Hani
(Cairo, Egypt) |
| |
|